Emmessar Biotech And Nutrition (BOM:524768) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Emmessar Biotech And Nutrition LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Emmessar Biotech And Nutrition's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Emmessar Biotech And Nutrition's long-term debt to total assets ratio stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

Emmessar Biotech And Nutrition LT-Debt-to-Total-Asset Historical Data

The historical data trend for Emmessar Biotech And Nutrition's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emmessar Biotech And Nutrition LT-Debt-to-Total-Asset Chart

Emmessar Biotech And Nutrition Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Emmessar Biotech And Nutrition Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Emmessar Biotech And Nutrition LT-Debt-to-Total-Asset Calculation

Emmessar Biotech And Nutrition's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	0	/	87.429
	=	0.00

Emmessar Biotech And Nutrition's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0	/	92.852
	=	0.00

Emmessar Biotech And Nutrition (BOM:524768) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Emmessar Biotech And Nutrition LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Emmessar Biotech And Nutrition's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Emmessar Biotech And Nutrition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emmessar Biotech And Nutrition Ltd (BOM:524768) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001

Website

https://www.ebnl.org

Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.

Emmessar Biotech And Nutrition Headlines

No Headlines